22 November 2022
Researchers in St. Petersburg have come up with what they say is an “effectual” drug candidate to treat Alzheimer’s related degenerative cerebral dysfunctions. The St. Petersburg Institute of Bioregulation and Gerontology and the Pavlov Institute of Physiology are behind the research effort.
As they experimented with Alzheimer’s mouse models, the scientists found out that using special peptides could help prevent and even reverse in the test mice’s brains the loss of what physiologists refer to as dendritic spines – special postsynaptic structures that are responsible for memory mechanisms and particularly involved in forming new memories – thus having cerebral functions fully restored.
The peptide candidate is considered “unique” and safe as no side effects have been reported.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Achieving FAIR bacterial identification
18 April 2024
Unique testing regimen could prevent nuclease contamination
18 April 2024
CRISPR technologies fuelling haematological innovations
17 April 2024
17 April 2024